Synectics plc (AIM: SNX), a leader in the design, integration and support of advanced security and surveillance systems, has been notified that on 1 April 2022, the Trustee of the Company's HMRC Approved Employee Share Acquisition Plan (“ESAP”) purchased a total of 16,180 ordinary shares of 20 pence each in the Company (“Ordinary Shares”) at an average price of £1.38725 per share in accordance with the ESAP's rules and on behalf of all ESAP participants, in respect of the six-month accumulation period ended on 31 March 2022.

Under the terms of the ESAP, participating members, including employees and certain Directors of the Company, contribute a fixed amount to the Trustee on a monthly basis. The Trustee acquires a number of shares at the end of the six-month accumulation period (the “Period”) based upon the contributions made in the Period and determined by the lowest share price at either the beginning of the Period or on the date of purchase. In this instance, the share price used for the allocation of the number of shares for ESAP purposes was the price per share at the beginning of the Period which was £1.04.

As a result of this purchase, the Company has been notified that the following Executive Directors and PDMRs have acquired the following interests in Ordinary Shares:

Name Position Status Number of Ordinary Shares purchased by the Trustee
Paul Webb Chief Executive Executive Director 865
David Bedford Finance Director Executive Director 865
Greg Alcorn Divisional Director PDMR 866


Following these purchases, the interests of Messrs Webb, Bedford and Alcorn in the shares of the Company are as follows:

Name Number of Ordinary Shares Held Interest in Ordinary Shares in Share Schemes Resultant Total Interest % of Issued Share Capital
Paul Webb 57,115 512,192 569,307 3.20%
David Bedford 20,000 187,722 207,722 1.17%
Greg Alcorn - 26,521 26,521 0.15%

For further information, please contact:

Synectics plc
Claire Stewart, Company Secretary
Tel: +44 (0) 114 280 2828

Shore Capital
Tom Griffiths / David Coaten
Tel: +44 (0) 207 408 4050